Citi Pharma (CPHL): 1QFY25 EPS at Rs0.88 up 32% QoQ (Earnings higher than expectations)
Citi Pharma (CPHL) announced its 1QFY25 result today, where the company recorded earnings of Rs201mn (EPS of Rs0.88), up 114% YoY and 32%...
45 Views
Pakistan Equity - Citi Pharma (CPHL) Joint Venture with Hangzhou Newsea Technology Co Limited
In a notice on the exchange, CPHL announced Joint Venture (JV) with Hangzhou Newsea Technology Co Limited, a renowned player in pharmaceutical...
218 Views
Pakistan Pharmaceuticals: Pharma Sector Analysis FY24; Deregulation Improved Sales and Margins
Pakistan listed pharmaceuticals sector's earnings were up 70% YoY to Rs13.3bn in fiscal year 2024. This jump in profitability is...
395 Views
No more insights